{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:56:27Z","timestamp":1790096187198,"version":"4.0.1"},"reference-count":131,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T00:00:00Z","timestamp":1682467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Portal Vein Thrombosis (PVT), a common complication of advanced liver disease, is defined as an obstruction of the portal vein due to thrombus formation that can extend to the superior mesenteric and splenic veins. It was believed that PVT occurred predominantly due to prothrombotic potential. However, recent studies have shown that decreased blood flow related to portal hypertension appears to increase PVT risk as per Virchow\u2019s triad. It is well known that there is a higher incidence of PVTs in cirrhosis with a higher MELD and Child Pugh score. The controversy for management of PVTs in cirrhotics lies in the individualized assessment of risks versus benefits of anticoagulation, since these patients have a complex hemostatic profile with both bleeding and procoagulant propensities. In this review, we will systematically compile the etiology, pathophysiology, clinical features, and management of portal vein thrombosis in cirrhosis.<\/jats:p>","DOI":"10.3389\/fmed.2023.1134801","type":"journal-article","created":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T05:41:31Z","timestamp":1682487691000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["Portal vein thrombosis in cirrhosis: A literature review"],"prefix":"10.3389","volume":"10","author":[{"given":"Swathi","family":"Prakash","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared","family":"Bies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Mares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Claudia","family":"Didia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,26]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.3748\/wjg.v12.i13.2115","article-title":"Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies","volume":"12","author":"Ogren","year":"2006","journal-title":"World J Gastroenterol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.jhep.2004.01.001","article-title":"Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis","volume":"40","author":"Amitrano","year":"2004","journal-title":"J Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.jhep.2021.07.020","article-title":"Predicting portal thrombosis in cirrhosis: a prospective study of clinical, ultrasonographic and hemostatic factors","volume":"75","author":"Turon","year":"2021","journal-title":"J Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3748\/wjg.v16.i2.143","article-title":"Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment","volume":"16","author":"Ponziani","year":"2010","journal-title":"World J Gastroenterol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.4254\/wjh.v7.i27.2774","article-title":"Portal vein thrombosis, mortality and hepatic decompensation in patients with cirrhosis: a meta-analysis","volume":"7","author":"Stine","year":"2015","journal-title":"World J Hepatol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1111\/jth.15797","article-title":"The portal vein in patients with cirrhosis is not an excessively inflammatory or hypercoagulable vascular bed, a prospective cohort study","volume":"20","author":"Driever","year":"2022","journal-title":"J Thromb Haemost"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1111\/liv.14404","article-title":"The impact of ABO blood type on the prevalence of portal vein thrombosis in patients with advanced chronic liver disease","volume":"40","author":"Scheiner","year":"2020","journal-title":"Liver Int"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.jhep.2021.07.020","article-title":"Predicting portal thrombosis in cirrhosis: A prospective study of clinical, ultrasonographic and hemostatic factors","volume":"75","author":"Turon","year":"2021","journal-title":"J Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/hep.27546","article-title":"Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a longitudinal study","volume":"61","author":"Nery","year":"2015","journal-title":"Hepatology"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"800","DOI":"10.3390\/jcm11030800","article-title":"The pathophysiology of portal vein thrombosis in cirrhosis: getting deeper into Virchow\u2019s triad","volume":"11","author":"Anton","year":"2022","journal-title":"J Clin Med"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1097\/MEG.0000000000000325","article-title":"De-novo portal vein thrombosis in liver cirrhosis: risk factors and correlation with the model for end-stage liver disease scoring system","volume":"27","author":"Abdel-Razik","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/liv.13500","article-title":"Decreased portal vein velocity is predictive of the development of portal vein thrombosis: A matched case-control study","volume":"38","author":"Stine","year":"2018","journal-title":"Liver Int"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1161\/ATVBAHA.118.310367","article-title":"Thrombotic regulation from the endothelial cell perspectives","volume":"38","author":"Wang","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12872-015-0124-z","article-title":"Endothelial cell control of thrombosis","volume":"15","author":"Yau","year":"2015","journal-title":"BMC Cardiovasc Disord"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1177\/0003319717732238","article-title":"Endothelial dysfunction and venous thrombosis","volume":"69","author":"Poredos","year":"2018","journal-title":"Angiology"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2310\/6650.2001.33785","article-title":"Increased soluble P-Selectin levels in hepatitis C virus-related chronic hepatitis. Correlation with viral load","volume":"49","author":"Ferroni","year":"2001","journal-title":"J Investig Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/hep.28853","article-title":"Low-grade endotoxemia and platelet activation in cirrhosis","volume":"65","author":"Raparelli","year":"2017","journal-title":"Hepatology"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e112583","DOI":"10.1371\/journal.pone.0112583","article-title":"Effects of increased von Willebrand factor levels on primary hemostasis in thrombocytopenic patients with liver cirrhosis","volume":"9","author":"Wannhoff","year":"2014","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/hep.21231","article-title":"Elevated levels of von Willebrand factor in cirrhosis support platelet adhesion despite reduced functional capacity","volume":"44","author":"Lisman","year":"2006","journal-title":"Hepatology"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e00123","DOI":"10.14309\/ctg.0000000000000123","article-title":"Von Willebrand and factor VIII Portosystemic circulation gradient in cirrhosis: implications for portal vein thrombosis","volume":"11","author":"Praktiknjo","year":"2020","journal-title":"Clin Transl Gastroenterol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/cyto.a.22647","article-title":"Microparticle analysis in disorders of hemostasis and thrombosis","volume":"89","author":"Mooberry","year":"2016","journal-title":"Cytometry A"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.thromres.2018.11.010","article-title":"Evaluation the combined diagnostic value of TAT, PIC, tPAIC, and sTM in disseminated intravascular coagulation: A multi-center prospective observational study","volume":"173","author":"Mei","year":"2019","journal-title":"Thromb Res"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1002\/hep.32169","article-title":"Nonmalignant portal vein thrombi in patients with cirrhosis consist of intimal fibrosis with or without a fibrin-rich thrombus","volume":"75","author":"Driever","year":"2022","journal-title":"Hepatology"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1055\/s-0037-1607202","article-title":"Venous and arterial Thromboses: two sides of the same coin?","volume":"44","author":"Lippi","year":"2018","journal-title":"Semin Thromb Hemost"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.jamcollsurg.2014.07.939","article-title":"Optimizing risk stratification in portal vein thrombosis after splenectomy and its primary prophylaxis with antithrombin III concentrates and danaparoid sodium in liver cirrhosis with portal hypertension","volume":"219","author":"Kawanaka","year":"2014","journal-title":"J Am Coll Surg"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.3892\/etm.2019.7300","article-title":"The risk factors of portal vein thrombosis in patients with liver cirrhosis","volume":"17","author":"Cagin","year":"2019","journal-title":"Exp Ther Med"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"5014","DOI":"10.3748\/wjg.v18.i36.5014","article-title":"What we should know about portal vein thrombosis in cirrhotic patients: a changing perspective","volume":"18","author":"Ponziani","year":"2012","journal-title":"World J Gastroenterol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/1471-230X-11-66","article-title":"High incidence of hepatitis B infection-associated cirrhosis and hepatocellular carcinoma in the southeast Asian patients with portal vein thrombosis","volume":"11","author":"Lertpipopmetha","year":"2011","journal-title":"BMC Gastroenterol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1111\/j.1872-034X.2009.00531.x","article-title":"Correlation of routinely used coagulation parameters and presence of portal vein thrombosis in patients with liver cirrhosis","volume":"39","author":"Weber","year":"2009","journal-title":"Hepatol Res"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.thromres.2012.11.003","article-title":"Coagulation imbalance may not contribute to the development of portal vein thrombosis in patients with cirrhosis","volume":"131","author":"Chen","year":"2013","journal-title":"Thromb Res"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1055\/s-0040-1722260","article-title":"Management of Portal Vein Thrombosis in cirrhosis","volume":"41","author":"Stotts","year":"2021","journal-title":"Semin Liver Dis"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/0016-5085(85)90327-0","article-title":"Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients","volume":"89","author":"Okuda","year":"1985","journal-title":"Gastroenterology"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1097\/00007890-200005150-00023","article-title":"Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome","volume":"69","author":"Yerdel","year":"2000","journal-title":"Transplantation"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1136\/gut.2004.042796","article-title":"Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation","volume":"54","author":"Francoz","year":"2005","journal-title":"Gut"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1097\/TP.0b013e31826e8e53","article-title":"Management of nonneoplastic portal vein thrombosis in the setting of liver transplantation: a systematic review","volume":"94","author":"Rodr\u00edguez-Castro","year":"2012","journal-title":"Transplantation"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.15761\/JTS.1000182","article-title":"Hemostasis, bleeding and thrombosis in liver disease","volume":"3","author":"Flores","year":"2017","journal-title":"J Transl Sci"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1053\/j.gastro.2019.01.265","article-title":"Diagnosis, development, and treatment of portal vein thrombosis in patients with and without cirrhosis","volume":"156","author":"Intagliata","year":"2019","journal-title":"Gastroenterology"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.dld.2009.08.003","article-title":"Portal vein thrombosis, revisited","volume":"42","author":"Primignani","year":"2010","journal-title":"Dig Liver Dis"},{"key":"ref39","first-page":"46","article-title":"Vascular liver disorders (II): portal vein thrombosis","volume":"67","author":"Hoekstra","year":"2009","journal-title":"Neth J Med"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1471-230X-7-34","article-title":"Portal vein thrombosis; risk factors, clinical presentation and treatment","volume":"7","author":"Sogaard","year":"2007","journal-title":"BMC Gastroenterol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1053\/jhep.2003.50232","article-title":"Portal cavernoma-associated cholangiopathy: a clinical and MR cholangiography coupled with MR portography imaging study","volume":"37","author":"Condat","year":"2003","journal-title":"Hepatology"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"315","DOI":"10.20524\/aog.2018.0245","article-title":"Portal vein thrombosis in cirrhosis: diagnosis, natural history, and therapeutic challenges","volume":"31","author":"Mantaka","year":"2018","journal-title":"Ann Gastroenterol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1053\/jhep.2003.50385","article-title":"Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators","volume":"38","author":"D\u2019Amico","year":"2003","journal-title":"Hepatology"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/hep.31646","article-title":"Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the American Association for the Study of Liver Diseases","volume":"73","author":"Northup","year":"2021","journal-title":"Hepatology"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1590\/0100-3984.2019.0109","article-title":"The ABCD of portal vein thrombosis: a systematic approach","volume":"53","author":"Minoda","year":"2020","journal-title":"Radiol Bras"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"14","DOI":"10.2214\/AJR.18.19548","article-title":"Portal vein thrombosis: imaging the Spectrum of disease with an emphasis on MRI features","volume":"211","author":"Jha","year":"2018","journal-title":"AJR Am J Roentgenol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2214\/ajr.157.2.1853809","article-title":"Diagnosis of portal vein thrombosis: value of color Doppler imaging","volume":"157","author":"Tessler","year":"1991","journal-title":"AJR Am J Roentgenol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1080\/028418500127345703","article-title":"Contrast-enhanced color Doppler US in malignant portal vein thrombosis","volume":"41","author":"Ricci","year":"2000","journal-title":"Acta Radiol"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ultrasmedbio.2018.09.009","article-title":"Characterization of malignant portal vein thrombosis with contrast-enhanced ultrasonography","volume":"45","author":"Chammas","year":"2019","journal-title":"Ultrasound Med Biol"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s004320050189","article-title":"Portal vein thrombosis in hepatocellular carcinoma: age and sex distribution in an autopsy study","volume":"124","author":"Pirisi","year":"1998","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"3290","DOI":"10.1007\/s10620-007-9808-2","article-title":"Hepatocellular carcinoma with portal vein tumor thrombosis: clinical characteristics, prognosis, and patient survival analysis","volume":"52","author":"Takizawa","year":"2007","journal-title":"Dig Dis Sci"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1007\/s00330-008-0931-z","article-title":"Contrast-enhanced ultrasonography and spiral computed tomography in the detection and characterization of portal vein thrombosis complicating hepatocellular carcinoma","volume":"18","author":"Rossi","year":"2008","journal-title":"Eur Radiol"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"938.e1","DOI":"10.1016\/j.crad.2016.05.002","article-title":"Dual-energy CT with iodine quantification in distinguishing between bland and neoplastic portal vein thrombosis in patients with hepatocellular carcinoma","volume":"71","author":"Ascenti","year":"2016","journal-title":"Clin Radiol"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0363-0188(92)90036-F","article-title":"Portal vein thrombosis: imaging features and associated etiologies","volume":"21","author":"Abbitt","year":"1992","journal-title":"Curr Probl Diagn Radiol"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"289","DOI":"10.21037\/atm-20-4912","article-title":"Increased portal vein diameter is predictive of portal vein thrombosis development in patients with liver cirrhosis","volume":"9","author":"Dong","year":"2021","journal-title":"Ann Transl Med"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ejrad.2019.07.008","article-title":"MRI in differentiating malignant versus benign portal vein thrombosis in patients with hepatocellular carcinoma: value of post contrast imaging with subtraction","volume":"118","author":"Gawande","year":"2019","journal-title":"Eur J Radiol"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1148\/radiol.2015150124","article-title":"Portal vein thrombosis in patients with hepatocellular carcinoma: diagnostic accuracy of Gadoxetic acid-enhanced MR imaging","volume":"279","author":"Kim","year":"2016","journal-title":"Radiology"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3348\/kjr.2016.17.4.533","article-title":"Diffusion-weighted MRI of malignant versus benign portal vein thrombosis","volume":"17","author":"Ahn","year":"2016","journal-title":"Korean J Radiol"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1159\/000505191","article-title":"How to best detect portal vein tumor thrombosis in patients with hepatocellular carcinoma meeting the Milan criteria: Gadoxetic acid-enhanced MRI versus contrast-enhanced CT","volume":"9","author":"Bae","year":"2020","journal-title":"Liver Cancer"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"989","DOI":"10.2214\/ajr.161.5.8273643","article-title":"Imaging of the portal venous system in patients with cirrhosis: MR angiography vs duplex Doppler sonography","volume":"161","author":"Finn","year":"1993","journal-title":"AJR Am J Roentgenol"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1002\/lt.20873","article-title":"Accuracy of magnetic resonance imaging for preoperative detection of portal vein thrombosis in liver transplant candidates","volume":"12","author":"Shah","year":"2006","journal-title":"Liver Transpl"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/hep.23259","article-title":"Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study","volume":"51","author":"Plessier","year":"2010","journal-title":"Hepatology"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ejim.2014.12.002","article-title":"Anticoagulation for the treatment of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis of observational studies","volume":"26","author":"Qi","year":"2015","journal-title":"Eur J Intern Med"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/1751-2980.12970","article-title":"Consensus for management of portal vein thrombosis in liver cirrhosis (2020, Shanghai)","volume":"22","year":"2021","journal-title":"J Dig Dis"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1053\/j.gastro.2017.04.042","article-title":"Effects of anticoagulants in patients with cirrhosis and portal vein thrombosis: A systematic review and meta-analysis","volume":"153","author":"Loffredo","year":"2017","journal-title":"Gastroenterology"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1097\/MEG.0000000000001846","article-title":"Efficacy and safety study of direct-acting oral anticoagulants for the treatment of chronic portal vein thrombosis in patients with liver cirrhosis","volume":"32","author":"Ai","year":"2020","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1016\/j.jvir.2013.08.018","article-title":"Portal vein thrombosis after partial splenic embolization in liver cirrhosis: efficacy of anticoagulation and long-term follow-up","volume":"24","author":"Cai","year":"2013","journal-title":"J Vasc Interv Radiol"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"S171","DOI":"10.1016\/S1590-8658(13)60485-5","article-title":"Clinical outcome of partial portal vein thrombosis in cirrhotic patients: to observe or to treat?","volume":"45","author":"Caracciolo","year":"2013","journal-title":"Dig Liver Dis"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/MEG.0000000000000482","article-title":"Efficacy and safety of anticoagulation in more advanced portal vein thrombosis in patients with liver cirrhosis","volume":"28","author":"Chen","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3350\/cmh.2014.20.4.384","article-title":"Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis","volume":"20","author":"Chung","year":"2014","journal-title":"Clin Mol Hepatol"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1097\/MEG.0000000000000351","article-title":"Efficacy and safety of anticoagulation therapy with different doses of enoxaparin for portal vein thrombosis in cirrhotic patients with hepatitis B","volume":"27","author":"Cui","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1111\/liv.13285","article-title":"Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis","volume":"37","author":"de Gottardi","year":"2017","journal-title":"Liver Int"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s12072-019-09933-8","article-title":"Management of HCV-related decompensated cirrhosis with direct-acting antiviral agents: who should be treated?","volume":"13","author":"Hanafy","year":"2019","journal-title":"Hepatol Int"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/ejh.12844","article-title":"The efficacy and safety of direct oral anticoagulants vs traditional anticoagulants in cirrhosis","volume":"98","author":"Hum","year":"2017","journal-title":"Eur J Haematol"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1007\/s10620-015-4012-2","article-title":"Direct Oral anticoagulants in cirrhosis patients pose similar risks of bleeding when compared to traditional anticoagulation","volume":"61","author":"Intagliata","year":"2016","journal-title":"Dig Dis Sci"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"209","DOI":"10.14740\/jocmr4718","article-title":"Risk factors, clinical presentation, diagnosis, and treatment outcomes of portal vein thrombosis: A five-year hospital-based study from Qatar","volume":"14","author":"Khan","year":"2022","journal-title":"J Clin Med Res"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.cgh.2017.10.016","article-title":"Harmful and beneficial effects of anticoagulants in patients with cirrhosis and portal vein thrombosis","volume":"16","author":"la Mura","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.14309\/ajg.0000000000001194","article-title":"Anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis: a prospective observational study","volume":"116","author":"Lv","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"686","DOI":"10.3109\/00365521.2012.674972","article-title":"Emergency anticoagulation treatment for cirrhosis patients with portal vein thrombosis and acute variceal bleeding","volume":"47","author":"Maruyama","year":"2012","journal-title":"Scand J Gastroenterol"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/hepr.12895","article-title":"Efficacy and safety of edoxaban for treatment of portal vein thrombosis following danaparoid sodium in patients with liver cirrhosis","volume":"48","author":"Nagaoki","year":"2018","journal-title":"Hepatol Res"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41395-018-0421-0","article-title":"Clinical impact and safety of anticoagulants for portal vein thrombosis in cirrhosis. Official journal of the American College of Gastroenterology","volume":"114","author":"Pettinari","year":"2019","journal-title":"ACG"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1016\/j.dld.2014.01.093","article-title":"Liver transplantation in cirrhotic patients with portal vein thrombosis: A single Centre experience","volume":"46","author":"Risso","year":"2014","journal-title":"Dig Liver Dis"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1111\/j.1478-3231.2012.02785.x","article-title":"Prospective evaluation of anticoagulation and transjugular intrahepatic portosistemic shunt for the management of portal vein thrombosis in cirrhosis","volume":"32","author":"Senzolo","year":"2012","journal-title":"Liver Int"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"e00228","DOI":"10.14309\/ctg.0000000000000228","article-title":"Efficacy and safety of Nadroparin calcium-warfarin sequential anticoagulation in portal vein thrombosis in cirrhotic patients: A randomized controlled trial","volume":"11","author":"Zhou","year":"2020","journal-title":"Clin Transl Gastroenterol"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"E107","DOI":"10.1111\/hepr.12934","article-title":"Antithrombin III for portal vein thrombosis in patients with liver disease: A randomized, double-blind, controlled trial","volume":"48","author":"Hidaka","year":"2018","journal-title":"Hepatol Res"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.dld.2021.07.039","article-title":"Efficacy and safety of direct oral anticoagulants versus vitamin K antagonist for portal vein thrombosis in cirrhosis: A systematic review and meta-analysis","volume":"54","author":"Koh","year":"2022","journal-title":"Dig Liver Dis"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.jhepr.2019.02.006","article-title":"Anticoagulation in the cirrhotic patient","volume":"1","author":"Turco","year":"2019","journal-title":"JHEP Rep"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1053\/j.gastro.2021.09.004","article-title":"AGA technical review on coagulation in cirrhosis","volume":"161","author":"Intagliata","year":"2021","journal-title":"Gastroenterology"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1055\/s-0039-1679934","article-title":"Direct-acting Oral anticoagulants (DOACs) in cirrhosis and cirrhosis-associated portal vein thrombosis","volume":"39","author":"Weinberg","year":"2019","journal-title":"Semin Liver Dis"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.2165\/11595540-000000000-00000","article-title":"Edoxaban: a new oral direct factor xa inhibitor","volume":"71","author":"Camm","year":"2011","journal-title":"Drugs"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s40262-013-0034-0","article-title":"Anticoagulant therapy with the oral direct factor Xa inhibitors rivaroxaban, apixaban and edoxaban and the thrombin inhibitor dabigatran etexilate in patients with hepatic impairment","volume":"52","author":"Graff","year":"2013","journal-title":"Clin Pharmacokinet"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1053\/j.gastro.2021.08.015","article-title":"AGA clinical practice guideline on the Management of Coagulation Disorders in patients with cirrhosis","volume":"161","author":"O\u2019Shea","year":"2021","journal-title":"Gastroenterology"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.jhep.2021.09.003","article-title":"EASL clinical practice guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis","volume":"76","year":"2022","journal-title":"J Hepatol"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"5179","DOI":"10.12998\/wjcc.v9.i19.5179","article-title":"Systematic review and meta-analysis of trans-jugular intrahepatic portosystemic shunt for cirrhotic patients with portal vein thrombosis","volume":"9","author":"Zhang","year":"2021","journal-title":"World J Clin Cases"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"5561","DOI":"10.3748\/wjg.v26.i37.5561","article-title":"Transjugular intrahepatic portosystemic shunt in cirrhosis: an exhaustive critical update","volume":"26","author":"Rajesh","year":"2020","journal-title":"World J Gastroenterol"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.3390\/jcm10112316","article-title":"Comparison of non-Tumoral portal vein thrombosis Management in Cirrhotic Patients: TIPS versus anticoagulation versus no treatment","volume":"10","author":"Zhan","year":"2021","journal-title":"J Clin Med"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"e8498","DOI":"10.1097\/MD.0000000000008498","article-title":"Portal vein thrombosis before and after transjugular intrahepatic portosystemic shunt placement: an observational study (STROBE compliant)","volume":"96","author":"Wan","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.hbpd.2020.12.016","article-title":"Transjugular intrahepatic portosystemic shunt is effective in patients with chronic portal vein thrombosis and variceal bleeding","volume":"20","author":"Sun","year":"2021","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3760\/cma.j.cn501113-20200804-00435","article-title":"Analysis of the short-and medium-term curative effect of TIPS approach combined with AngioJet thrombus aspiration technology treatment in acute portal vein thrombosis","volume":"29","author":"Zhang","year":"2021","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1136\/gutjnl-2017-314634","article-title":"Covered TIPS versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: a randomised controlled trial","volume":"67","author":"Lv","year":"2018","journal-title":"Gut"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1148\/radiol.15141252","article-title":"Advanced cirrhosis combined with portal vein thrombosis: a randomized trial of TIPS versus endoscopic band ligation plus propranolol for the prevention of recurrent esophageal Variceal bleeding","volume":"276","author":"Luo","year":"2015","journal-title":"Radiology"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.dld.2010.06.001","article-title":"Transjugular intrahepatic portosystemic shunt with expanded-polytetrafuoroethylene-covered stents in non-cirrhotic patients with portal cavernoma","volume":"43","author":"Fanelli","year":"2011","journal-title":"Dig Liver Dis"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3760\/cma.j.issn.0376-2491.2020.05.014","article-title":"Transjugular intrahepatic portosystemic shunt for the treatment cavernous transformation of the portal vein with vareceal bleeding","volume":"100","author":"Guo","year":"2020","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.jvir.2014.12.012","article-title":"Portal vein recanalization-transjugularintrahepatic portosystemic shunt using the transsplenic approach to achieve transplant candidacy in patients with chronic portal vein thrombosis","volume":"26","author":"Habib","year":"2015","journal-title":"J Vasc Interv Radiol"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jhep.2010.06.029","article-title":"Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis","volume":"54","author":"Han","year":"2011","journal-title":"J Hepatol"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.3748\/wjg.v10.i13.1881","article-title":"Transjugular intrahepatic portosystemic shunt for palliative treatment of portal hypertension secondary to portal vein tumor thrombosis","volume":"10","author":"Jiang","year":"2004","journal-title":"World J Gastroenterol"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"7470","DOI":"10.3748\/wjg.v23.i41.7470","article-title":"Clinical outcomes of transcatheter selective superior mesenteric artery urokinase infusion therapy vs transjugular intrahepatic portosystemic shunt in patients with cirrhosis and acute portal vein thrombosis","volume":"23","author":"Jiang","year":"2017","journal-title":"World J Gastroenterol"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/1751-2980.12702","article-title":"Transjugular intrahepatic portosystemic shunt prevents rebleeding in cirrhotic patients having cavernous transformation of the portal vein without improving their survival","volume":"20","author":"Li","year":"2019","journal-title":"J Dig Dis"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1136\/gut.2010.228023","article-title":"Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis","volume":"60","author":"Luca","year":"2011","journal-title":"Gut"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1148\/radiol.15141252","article-title":"Advanced cirrhosis combined with portal vein thrombosis: A randomized trial of TIPS versus endoscopic band ligation plus propranolol for the prevention of recurrent esophageal Variceal bleeding","volume":"276","author":"Luo","year":"2015","journal-title":"Radiology"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1148\/radiol.2017162266","article-title":"Association of Nonmalignant Portal Vein Thrombosis and Outcomes after Transjugular intrahepatic Portosystemic shunt in patients with cirrhosis","volume":"285","author":"Lv","year":"2017","journal-title":"Radiology"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1097\/MEG.0000000000001680","article-title":"Transjugular intrahepatic portosystemic shunt in cirrhotic patients with portal vein thrombosis","volume":"32","author":"Modaresi Esfeh","year":"2020","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"887","DOI":"10.12998\/wjcc.v8.i5.887","article-title":"Computed tomography-based score model\/nomogram for predicting technical and midterm outcomes in transjugular intrahepatic portosystemic shunt treatment for symptomatic portal cavernoma","volume":"8","author":"Niu","year":"2020","journal-title":"World J Clin Cases"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1097\/MEG.0b013e328338d995","article-title":"Feasibility and long-term evolution of TIPS in cirrhotic patients with portal thrombosis","volume":"22","author":"Perarnau","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref115","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/liv.12929","article-title":"Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with variceal bleeding in liver cirrhosis: outcomes and predictors in a prospective cohort study","volume":"36","author":"Qi","year":"2016","journal-title":"Liver Int"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1111\/j.1365-2036.2006.02820.x","article-title":"Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation","volume":"23","author":"Senzolo","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S1051-0443(99)70044-8","article-title":"Symptomatic spleno-mesenteric-portal venous thrombosis: recanalization and reconstruction with endovascular stents","volume":"10","author":"Stein","year":"1999","journal-title":"J Vasc Interv Radiol"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1016\/j.jvir.2017.08.005","article-title":"Pretransplantation portal vein recanalization and Transjugular intrahepatic Portosystemic shunt creation for chronic portal vein thrombosis: final analysis of a 61-patient cohort","volume":"28","author":"Thornburg","year":"2017","journal-title":"J Vasc Interv Radiol"},{"key":"ref119","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s00270-005-0090-4","article-title":"Transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis and concomitant portal vein thrombosis","volume":"29","author":"Van Ha","year":"2006","journal-title":"Cardiovasc Intervent Radiol"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1007\/s00261-014-0320-9","article-title":"Clinical outcome comparison between TIPS and EBL in patients with cirrhosis and portal vein thrombosis","volume":"40","author":"Wang","year":"2015","journal-title":"Abdom Imaging"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"737984","DOI":"10.3389\/fmed.2021.737984","article-title":"Comparison of Transjugular intrahepatic Portosystemic shunt in the treatment of cirrhosis with or without portal vein thrombosis: A retrospective study","volume":"8","author":"Wang","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1148\/radiol.2015150369","article-title":"Is post-TIPS anticoagulation therapy necessary in patients with cirrhosis and portal vein thrombosis? A randomized controlled trial","volume":"279","author":"Wang","year":"2016","journal-title":"Radiology"},{"key":"ref123","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1080\/00365521.2022.2094724","article-title":"Comparison of transjugular intrahepatic portosystemic with endoscopic treatment plus anticoagulation for esophageal variceal bleeding and portal vein thrombosis in liver cirrhosis","volume":"57","author":"Wu","year":"2022","journal-title":"Scand J Gastroenterol"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1055\/a-1642-0990","article-title":"Portal vein thrombosis: diagnosis and endovascular management","volume":"194","author":"Ju","year":"2022","journal-title":"Rofo"},{"key":"ref125","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1053\/j.tvir.2016.01.005","article-title":"Thrombolysis and Transjugular intrahepatic Portosystemic shunt creation for acute and subacute portal vein thrombosis","volume":"19","author":"Chamarthy","year":"2016","journal-title":"Tech Vasc Interv Radiol"},{"key":"ref126","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1097\/01.RVI.0000156265.79960.86","article-title":"Transcatheter thrombolytic therapy for acute mesenteric and portal vein thrombosis","volume":"16","author":"Hollingshead","year":"2005","journal-title":"J Vasc Interv Radiol"},{"key":"ref127","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1055\/s-0038-1660798","article-title":"Acute portal vein thrombosis: current trends in medical and endovascular management","volume":"35","author":"Seedial","year":"2018","journal-title":"Semin Intervent Radiol"},{"key":"ref128","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3760\/cma.j.issn.0376-2491.2020.07.011","article-title":"Clinical application and efficacy of TIPS combined with AngioJet mechanical thrombectomy for liver cirrhosis with extensive portal vein thrombosis","volume":"100","author":"Zhang","year":"2020","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"ref129","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s00270-022-03286-w","article-title":"Large bore portal vein thrombectomy: an Inari FlowTriever case series","volume":"46","author":"Sullivan","year":"2022","journal-title":"Cardiovasc Intervent Radiol"},{"key":"ref130","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1053\/j.gastro.2012.07.018","article-title":"Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis","volume":"143","author":"Villa","year":"2012","journal-title":"Gastroenterology"},{"key":"ref131","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ijsu.2019.02.018","article-title":"Warfarin versus aspirin prevents portal vein thrombosis after laparoscopic splenectomy and azygoportal disconnection: A randomized clinical trial","volume":"64","author":"Bai","year":"2019","journal-title":"Int J Surg"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1134801\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T05:41:41Z","timestamp":1682487701000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1134801\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,26]]},"references-count":131,"alternative-id":["10.3389\/fmed.2023.1134801"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1134801","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,26]]},"article-number":"1134801"}}